Olympia Pharmaceuticals, operating as both a 503B FDA-registered outsourcing facility and an affiliated 503A compounding pharmacy, has expanded its product directory to include a wide array of injectable peptides and wellness compounds. The company highlights its ability to provide these medications, including popular weight management and longevity agents, to physicians for office use and directly to patients via prescription. This expansion reflects the growing compounding industry response to high demand and shortages of branded peptide drugs.